Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease

Roeseler, E.; Julius, Ulrich; Heigl, Franz; Spitthoever, Ralf; Heutling, Dennis; Breitenberger, Paul; Leebmann, Josef; Lehmacher, Walter; R. Kamstrup, Pia; G. Nordestgaard, Børge; Maerz, Winfried; Noureen, Asma; Schmidt, Konrad; Kronenberg, Florian; Heibges, Andreas; Klingel, Reinhard; Schettler, Volker; Benzing, Thomas; Christ, Hildegard; Wehner, S.; Schulz-Merkel, Ines; Kuehn, Ralf; Wagner, Albrecht; Dschietzig, W; Ernst, Claudia; Koziolek, Michael; Bunia, Johannes; Kulzer, Peter; Kraenzle, Klaus-Dieter; Toelle, M.; Riechers, Gerhard; Kuehnel, Christine; A. Marsen, Tobias; Saehn, Christina; Ringel, J; Messner, Harald; Oehring, Andreas; Schuerfeld, Carsten; Wintergalen, Michael; Schettler, Volker; Neumann, Falko; Kaul, Harald; Haesner, Martin; Paßfall, J.; Benschneider, Andrea; Heidenreich, Stefan; März, Winfried; Klaes, Ruediger; Binner, Priska; Dieplinger, Hans; Erhart, Gertraud; Fassbender, Cordula; Christ, Hildegard

doi:10.1161/atvbaha.116.307983

Public

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease

Published in Arteriosclerosis Thrombosis and Vascular Biology • Jul 15, 2016

Authors:

E. Roeseler

Ulrich Julius

Franz Heigl

Abstract

OBJECTIVE: Lipoprotein(a)-hyperlipoproteinemia (Lp(a)-HLP) along with progressive cardiovascular disease has been approved as indication for regular lipoprotein apheresis (LA) in Germany since 2008. We aimed to study the long-term preventive effect of LA and to assess hypothetical clinical correlati...

Subject

Medicine

Lipoprotein(a)

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!